Health science reports · 2026
Lung Cancer in Never Smokers-An Underappreciated Public Health Burden.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mohiuddin Md
Аннотация
BACKGROUND: Lung cancer in lifelong never-smokers represents a significant public health burden, although it is underappreciated. Lung cancer in never smokers (LCINS) accounts for a substantial proportion of lung cancer cases, representing ~15%-25% depending on the geographic region. If considered as a separate disease entity, LCINS would represent a major cause of cancer-related mortality.
DISCUSSION: Importantly, never-smokers with lung cancer have distinct epidemiology, molecular alterations, and therapeutic opportunities that differ from those of tobacco-related lung cancer. This perspective addresses lung cancer in lifelong never-smokers from four perspectives: epidemiology and incidence, molecular landscape and treatment, screening and early detection, and public health strategies.
CONCLUSION: This perspective highlights that a comprehensive approach to lung cancer in never-smokers can meaningfully reduce the burden of disease through comprehensive screening approaches, stringent environmental regulations, molecular characterization of cancer, and educational approaches aimed at preventing disease.
DISCUSSION: Importantly, never-smokers with lung cancer have distinct epidemiology, molecular alterations, and therapeutic opportunities that differ from those of tobacco-related lung cancer. This perspective addresses lung cancer in lifelong never-smokers from four perspectives: epidemiology and incidence, molecular landscape and treatment, screening and early detection, and public health strategies.
CONCLUSION: This perspective highlights that a comprehensive approach to lung cancer in never-smokers can meaningfully reduce the burden of disease through comprehensive screening approaches, stringent environmental regulations, molecular characterization of cancer, and educational approaches aimed at preventing disease.